Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Brain Activation and Satiety in Children: Functional Magnetic Resonance Imaging (BASIC-FMRI)

5 de setembro de 2018 atualizado por: Christian Roth, Seattle Children's Hospital

Brain Systems and Behaviors Underlying Response to Obesity Treatment in Children

BASIC fMRI is a prospective single center intervention trial using fMRI imaging in 9-11 year old obese male and females pre and post family-based behavioral treatment of 24 weeks duration to determine the relationship between impulsivity and central satiety responses.

Visão geral do estudo

Status

Concluído

Condições

Descrição detalhada

The high prevalence of childhood obesity in the U.S. demands a better understanding of factors that drive weight gain and influence the outcome of pediatric obesity interventions. This project investigates the hypothesis that, as in adults, a subset of obese children experience a diminished satiety response to food consumption, and that these children are more resistant to gold standard family-based behavioral treatment (FBT) for obesity. FBT is targeted almost exclusively toward parents; however, there is evidence that obesity development and response to intervention may depend on additional factors such as individual internal satiety perception and variability in the function of brain centers associated with impulsivity and reward. The proposed research uses functional magnetic resonance imaging (fMRI) to characterize brain function related to satiety and examines fMRI along with behavioral, cognitive, and hormonal testing to fully examine potential mediators of children's experience of satiety and response to FBT. The approach is based on evidence that failure to attenuate the reward value of palatable foods after eating can be a manifestation of a blunted central satiety response that is reliably detected using fMRI. Key objectives will be to determine if differences in the central satiety response exist between obese and non-obese children, and, among obese children, if the strength of the central satiety response is associated with impulsivity and/or the success of obesity treatment. The central hypothesis is that, in obese children, a blunted central nervous system satiety response impairs the success of obesity interventions. To achieve study objectives, brain activation by high-calorie visual food cues before and after food consumption will be measured by fMRI. Participants will be obese and non-obese children aged 9-11 years. The 49 obese children will be evaluated before and after they participate in a 6-month evidence-based FBT intervention. Their pre-intervention fMRI will be compared to those of 20 non-obese controls to test for a blunted central satiety response (Aim 1). The relationship of impulsivity to satiety responses and food intake will be determined in obese children (Aim 2). The longitudinal component tests whether central satiety responses prior to treatment predict treatment outcomes (Aim 3A) and whether changes in central satiety responses during treatment predict maintenance of reduced weight 6 and 12 months after treatment cessation (Aim 3B). Behavioral, cognitive, and hormonal measures will be examined as potential mediating or confounding factors contributing to fMRI responses. The proposed research is guided by an integrated, transdisciplinary team with expertise in pediatric and adult neuroimaging, appetite regulation, and family-based childhood obesity treatment. This research will provide new insights into the neurobiological basis of child obesity and the relevance of neurobiological factors to treatment success. The long-term objective is to translate these findings to improve obesity interventions cost-effectively and sustain better long-term results.

During years 1-3, obese children will be enrolled into intervention groups of 9-11 families with staggered start dates by 3-6 months. Years 1-4 includes enrollment, intervention, longitudinal follow-up, and data collection for obese children. Control children will primarily be recruited during years 2-3 to facilitate matching. FMRI scans are processed on a rolling basis as studies are completed. In years 3 and 4 hormonal assays will be performed. Final data analyses will be completed in year 4.

Tipo de estudo

Intervencional

Inscrição (Real)

81

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Locais de estudo

    • Washington
      • Seattle, Washington, Estados Unidos, 89105
        • Seattle Childrens Hospital

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

9 anos a 11 anos (Filho)

Aceita Voluntários Saudáveis

Sim

Gêneros Elegíveis para o Estudo

Tudo

Descrição

Inclusion Criteria:

  • 9-11 years of age
  • Male or female
  • Ability and willingness to participate in study visits including fMRI scans and blood draws;
  • ability to provide informed written consent and assent;
  • BMI z-score for lean control children 15th to 84.9th perc. for age and sex,
  • BMI z-score for obese children BMI z-score >90th perc. for age and sex;
  • Additional inclusion criteria for obese children: One overweight parent (BMI >25 kg/m2); willingness of 1 parent (does not have to be the obese parent) to engage in family-based weight control treatment.

Exclusion Criteria:

  • History of acute or chronic serious medical conditions;
  • known diabetes mellitus or recent (6 mo.) history of anemia;
  • presence of any implanted metal or metal devices, including ferro-metallic surgical clips or braces;
  • claustrophobia;
  • documented cognitive disorder, disruptive behavior, inability to participate in group sessions;
  • current use of medications known to alter appetite, body weight, or brain response (e.g. anti-seizure medications, glucocorticoids, medications for attention deficit disorder);
  • food intolerance or vegetarianism.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Ciência básica
  • Alocação: N / D
  • Modelo Intervencional: Atribuição de grupo único
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Family Based Behavioral Treatment
Central satiety brain and hormonal responses will be compared pre-and post-Family Based Behavioral Treatment, as well, as to a non-obese sample.
Obese children accompanied by at least one parent or caregiver will attend 24 weekly in-person sessions. Sessions will include 25-30 min. meetings between an interventionist and each child/parent pair to individualize treatment, followed by separate child and parent group meetings lasting 40 - 45 min. Parents will serve as primary agents of change for their child and for themselves. Training will focus on food and physical activity education, parenting around food and physical activity, and use of behavioral skills (e.g., self-monitoring, environmental control, contingency management). Intervention groups of 9-11 children/families will be initiated every 3-6 mos. in study yrs. 1-3.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Prazo
Blunted central satiety response measured by functional magnetic resonance imaging
Prazo: Baseline
Baseline

Medidas de resultados secundários

Medida de resultado
Prazo
Change of brain response to visual food cues or eating behavior measured by functional magnetic resonance imaging
Prazo: Change from pre- to post-treatment (end of 6 month intervention)
Change from pre- to post-treatment (end of 6 month intervention)
Relationship between impulsivity and satiety in obese children as measured by functional magnetic resonance imaging.
Prazo: Change from pre- to post-treatment (end of 6 month intervention)
Change from pre- to post-treatment (end of 6 month intervention)
Relationship between impulsivity and satiety in obese children as measured by the Relative Reinforcing Value of Food (RRV).
Prazo: Change from pre- to post-treatment (end of 6 month intervention)
Change from pre- to post-treatment (end of 6 month intervention)
Relationship between impulsivity and satiety in obese children as measured by the Developmental NEuroPSYchological Assessment (NEPSY).
Prazo: Change from pre- to post-treatment (end of 6 month intervention)
Change from pre- to post-treatment (end of 6 month intervention)
Relationship between impulsivity and satiety in obese children as measured by the Delayed Choice Questionnaire (DCQ).
Prazo: Change from pre- to post-treatment (end of 6 month intervention)
Change from pre- to post-treatment (end of 6 month intervention)

Outras medidas de resultado

Medida de resultado
Prazo
Predictors of treatment outcomes measured by functional magnetic resonance imaging.
Prazo: Change from pre- to post-treatment (end of 6 month intervention)
Change from pre- to post-treatment (end of 6 month intervention)
Predictors of treatment outcomes measured by behavioral skills use questionnaires.
Prazo: Change from pre- to post-treatment (end of 6 month intervention)
Change from pre- to post-treatment (end of 6 month intervention)
Predictors of treatment outcomes measured by hormonal measures.
Prazo: Change from pre- to post-treatment (end of 6 month intervention)
Change from pre- to post-treatment (end of 6 month intervention)

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Colaboradores

Investigadores

  • Investigador principal: Christian Roth, MD, Seattle Children's

Publicações e links úteis

A pessoa responsável por inserir informações sobre o estudo fornece voluntariamente essas publicações. Estes podem ser sobre qualquer coisa relacionada ao estudo.

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo

1 de setembro de 2014

Conclusão Primária (Real)

1 de julho de 2018

Conclusão do estudo (Real)

1 de agosto de 2018

Datas de inscrição no estudo

Enviado pela primeira vez

20 de novembro de 2014

Enviado pela primeira vez que atendeu aos critérios de CQ

25 de junho de 2015

Primeira postagem (Estimativa)

30 de junho de 2015

Atualizações de registro de estudo

Última Atualização Postada (Real)

6 de setembro de 2018

Última atualização enviada que atendeu aos critérios de controle de qualidade

5 de setembro de 2018

Última verificação

1 de setembro de 2018

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

3
Se inscrever